Create a free account to unlock full content!
By registering, you agree to our Privacy Statement and Terms and Conditions.
| Program start date | Application deadline |
| 2026-11-27 | - |
| 2027-11-27 | - |
Program Overview
Postgraduate Course in Pharmacovigilance
The Postgraduate Course in Pharmacovigilance aims to provide basic pharmacovigilance knowledge, including regulatory and organizational aspects applicable in public or private facilities. The course training can be applied in managing pharmacovigilance reports, bioethical aspects, pharmaceutical registration, and pharmacovigilance of organic drugs, vaccines, biosimilar medicines, phytotherapeutic, and cosmetic products.
Learning Content
The Postgraduate Course in Pharmacovigilance delves into topics such as Pharmacology and Pathology, and Pharmaceutical Regulations, providing basic pharmacovigilance knowledge applicable in public and private structures. At the end of the course, students will have the basic elements to judge quality in pharmacovigilance report management independently. Students can also update their knowledge continuously, using IT tools to consult databases and scientific literature, with a focus on learning how to manage interactions within the European community in English.
Recipients and Career Opportunities
The Postgraduate Course in Pharmacovigilance trains students on pharmacovigilance in public and private hospital structures, pharmaceutical industries, and CRO. The purpose of the course is to help students gain independence in managing pharmacovigilance processes concerning drugs, biosimilar medicines, vaccines, generics, and phytotherapeutic and cosmetic products.
Program
The Postgraduate Course in Pharmacovigilance includes the following modules:
- Module 1: Pharmacology and Pathology
- Course unit contents: Pharmacokinetics/pharmacodynamics and Pharmacogenetics/pharmacogenomics. Subpopulations at risk of ADR. Iatrogenic pathology. Introduction to pharmacovigilance.
- Module 2: Pharmaceutical Legislation (1)
- Course unit contents: Development and registration of a drug. Clinical trials, GCP, and the role of CROs. The pharmaceutical industry in Italy. EMA and AIFA.
- Module 3: Pharmaceutical Legislation (2)
- Course unit contents: Pharmacovigilance in clinical trials. Phytovigilance. Cosmetovigilance.
- Module 4: Pharmaceutical Legislation (3)
- Course unit contents: The drug in postmarketing: the private sector.
General Information
- Thematic area: Health, environment, and territory
- End of classes: 03/07/2026
- Mandatory attendance: 70%
- Minimum available spots: 10
- Maximum available spots: 25
- First installment: 822.50
- Second installment: 400.00
- Total enrollment fee: 1,222.50
- Duration: One year
- Venue: Padova
- Language: Italian
- ECTS: 8
- Teaching method: Distance learning
- Pre-enrollment deadline: 24/11/2025
- Classes start: 27/11/2025
Management and Teaching
- The course will be taught by 16 professors from the private sector.
- There will be no internships or apprenticeships.
- Attendance is mandatory, with a minimum requirement of 70% of the lessons.
- The course will include a final exam through multiple-choice questions relating to each lesson held by the teachers.
- The course structure includes 50 hours of distance learning divided into 8 days of 6/8 hours each, distributed over three months in four modules of two days (Thursday and Friday).
